Differential CD74 (major histocompatibility complex Class II invariant chain) expression in mouse and human intestinal adenomas

European Journal of Cancer

Volumn 45, Issue 9, 2009, Pages 1654-1663

  Cuthbert, R J ^a   Wilson, J M ^a   Scott, N ^a   Coletta, P L ^a   Hull, M A ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Adenoma; CD74; Class II trans activator; Colorectal cancer; Invariant chain; Macrophage migration inhibitory factor

Indexed keywords

CD74 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; MIGRATION INHIBITION FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; CARCINOGENESIS; COLORECTAL ADENOMA; CONTROLLED STUDY; DOWN REGULATION; DYSPLASIA; FEMALE; GENE CONTROL; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOMA; ANIMALS; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; ANTIGENS, NEOPLASM; COLORECTAL NEOPLASMS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TRANS-ACTIVATORS;

EID: 65849215445     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.02.005     Document Type: Article

References (28)

1. Stumptner-Cuvelette P., and Benaroch P. Multiple roles of the invariant chain in MHC Class II function. Biochim Biophys Acta 1542 (2002) 1-13
2. Ong G.L., Goldenberg D.M., Hansen H.J., and Mattes M.J. Cell surface expression and metabolism of major histocompatibility complex class II invariant chain (CD74) by diverse cell lines. Immunology 98 (1999) 296-302
3. Leng L., Metz C.N., Fang Y., et al. MIF signal transduction initiated by binding to CD74. J Exp Med 197 (2003) 1467-1476
4. Shi X., Leng L., Wang T., et al. CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 25 (2006) 595-606
5. Bucala R., and Donnelly S.C. Macrophage migration inhibitory factor: a probable link between inflammation and cancer. Immunity 26 (2007) 281-285
6. Wilson J.M., Coletta P.L., Cuthbert R.J., et al. Macrophage migration inhibitory factor promotes intestinal tumorigenesis. Gastroenterology 129 (2005) 1485-1503
7. Degener T., Momburg F., and Moller P. Differential expression of HLA-DP, HLA-DQ and associated invariant chain (Ii) in normal colorectal mucosa, adenoma and carcinoma. Virchows Arch A Pathol Anat Histopathol 412 (1988) 315-322
8. Jiang Z., Xu M., Savas L., LeClair P., and Banner B.F. Invariant chain expression in colon neoplasms. Virchows Arch 435 (1999) 32-36
9. O'Keane J.C., Stahl D., Sheahan K., Burke B., Gottlieb L.S., and O'Brien M.J. Analysis of epithelial and lymphoid phenotypic markers in relation to growth pattern of colorectal adenomas. Hum Pathol 23 (1992) 1038-1043
10. Morand E.F., Leech M., and Bernhagen J. MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nature Rev Drug Discov 5 (2006) 399-411
11. Stein R., Mattes M.J., Cardillo T.M., et al. CD74: a new candidate target for the immunotherapy of B-cell neoplasms. Clin Cancer Res 13 18 Suppl (2007) 5556s-5563s
12. Min/+ mouse. Gastroenterology 121 (2001) 889-899
13. Min/+ mouse model of intestinal tumorigenesis. Carcinogenesis 27 (2006) 382-391
14. Elliott E.A., Drake J.R., Amigorena S., et al. The invariant chain is required for intracellular transport and function of major histocompatibility complex Class II molecules. J Exp Med 179 (1994) 681-694
15. Ko C.W.S., Cuthbert R.J., Orsi N.M., et al. Lack of interleukin-4 receptor α chain-dependent signalling promotes azoxymethane-induced colonic aberrant crypt focus formation in Balb/c mice. J Pathol 214 (2008) 603-609
16. Vandesompele J., de Preter K., Pattyn F., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3 (2002) research0034
17. Boivin G.P., Washington K., Yang K., et al. Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology 124 (2003) 762-777
18. Koch N., Lauer W., Habicht J., and Dobberstein B. Primary structure of the gene for the murine Ia antigen-associated invariant chains (Ii). An alternatively spliced exon encodes a cysteine-rich domain highly homologous to a repetitive sequence of thyroglobulin. EMBO J 6 (1987) 1677-1683
19. Yamamoto K., Koch N., Steinmetz M., and Hammerling G.J. One gene encodes two distinct Ia-associated invariant chains. J Immunol 134 (1985) 3461-3467
20. Wright K.L., and Ting J.P.-Y. Epigenetic regulation of MHC-II and CIITA genes. Trends Immunol 27 (2006) 405-412
21. Sanderson I.R., Bustin S.A., Dziennis S., Paraszczuk J., and Stamm D.S. Age and diet act through distinct isoforms of the Class II transactivator gene in mouse intestinal epithelium. Gastroenterology 127 (2004) 203-212
22. Steimle V., Siegrist C.A., Mottet A., Lisowska-Grospierre B., and Mach B. Regulation of MHC Class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265 (1994) 106-109
23. McClelland M., Zhao L., Carskadon S., and Arenberg D. Expression of CD74, the receptor for macrophage migration inhibitory factor, in non-small cell lung cancer. Am J Pathol 174 (2009) 638-646
24. Starlets D., Gore Y., Binsky I., et al. Cell-surface CD74 initiates a signalling cascade leading to cell proliferation and survival. Blood 107 (2006) 4807-4816
25. Corpet D.E., and Pierre F. How good are rodent models of carcinogenesis in predicting efficacy in humans? Systematic review and meta-analysis of colon tumour chemoprevention in rats, mice and men. Eur J Cancer 41 (2005) 1911-1922
26. Mitchell R.A. Mechanisms and effectors of MIF-dependent promotion of tumourigenesis. Cell Signal 16 (2004) 13-19
27. Holling T.M., van Eggermond M.C.J.A., Jager M.J., and van den Elsen P.J. Epigenetic silencing of MHC2TA transcription in cancer. Biochem Pharmacol 72 (2006) 1570-1576
28. Satoh A., Toyota M., Ikeda H., et al. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-γ-induced HLA-DR expression in colorectal and gastric cancer cells. Oncogene 23 (2004) 8876-8886